High Content Screening (HCS) Market To Surpass US$ 2,387.9 Million By 2027- Coherent Market Insights

1. HIGH CONTENT SCREENING MARKET ANALYSIS INDUSTRY INSIGHTS, TRENDS, OUTLOOK, AND OPPORTUNITY ANALYSIS, 2020–2027 © Coherent market Insights. All Rights Reserved © Coherent market Insights. All Rights Reserved

2. REPORT DESCRIPTION High Content Screening Market - Overview A major application of high-content screening (HCS) is cell screening and profiling. HCS involves the use of simultaneous recording of multiple parameters in cell-based assays. During early stages of drug discovery, HCS offers unique approaches to integrate disease- relevant cell screening, thereby offering enhanced secondary cell analysis. The global High Content Screening (HCS) Market is estimated to account for US$ 1,404.6 Mn in terms of value in 2018 and is expected to reach US$ 2,387.9 by the end of 2027. Global High Content Screening (HCS) Market: Drivers Development of novel HCS approaches is also expected to boost growth of the global high content screening (HCS) market over the forecast period. For instance, in January 2020, researchers from Scripps Research Institute reported development of neuron- based high-content assay and screen that can be used for R&D of medicines for neurodegenerative diseases. Global High Content Screening (HCS) Market: Restraints High prices of HCS equipment is also expected to hamper growth of the market. For instance, a confocal microscope can cost over US$ 200,000. Browse Research Reports: https://www.coherentmarketinsights.com/market-insight/high- content-screening-market-3487 © Coherent market Insights. All Rights Reserved

3. REPORT DESCRIPTION Key Takeaways: Cell imaging and analysis equipment segment in the global high content screening (HCS) market was valued at US$ 550.1 Mn in 2018 and is expected to reach US$ 911.3 Mn by 2027 at a CAGR of 5.8% during the forecast period. Rising product approvals and product launch by the market players is expected to propel the market growth. For instance, in February 2018, Molecular Devices, LLC, launched ImageXpress Pico Automated Cell Imaging System which automates the manual procedures such as acquisition steps and post processing of images and offers user efficient tool in research work The primary cell screening segment held dominant position in the global high content screening (HCS) market in 2018, accounting for 36.8% share in terms of value, followed by target identification & validation and toxicity studies, respectively. Primary cell screening involves analysis of parameters such as cell structure, cell function analysis, and others which is important for several studies such as drug development, disease progression studies, cancer research and others. The pharmaceutical industries segment held dominant position in the global high content screening (HCS) market in 2018, accounting for 35.0% share in terms of value, followed by biotechnology and research institutes, respectively. Request a Sample copy of this reports: https://www.coherentmarketinsights.com/insight/request-sample/3487 © Coherent market Insights. All Rights Reserved

4. REPORT DESCRIPTION Market Trends HCS finds application in marine biotechnology. For instance, in October 2018, researchers from National Sun Yat-Sen University reported use of HCS in discovery of novel proteasome inhibitors from formosan soft corals. HCS can also be used for screening of natural products. For instance, in July 2018, researchers from Kaohsiung Medical University (Taiwan) reported use of HCS for screening Taiwanese indigenous plant extract library to identify syzygium simile leaf extract as an inhibitor of fatty acid uptake. Global High Content Screening (HCS) Market: Competitive Landscape Major players operating in the global high content screening (HCS) market include, Becton, Dickinson and Company, Thermo Fisher Scientific Inc., GE Healthcare, Olympus Corporation, PerkinElmer Inc. Global High Content Screening (HCS) Market: Key Developments Major players in the market are also focused on adopting collaboration and partnership strategies to expand their product portfolio. For instance, in December 2019: SCIEX joined the Ready-to-Run Partner Program at Genedata, a provider of advanced software solutions for biopharmaceutical R&D, under which both the companies will address increasing data analysis requirements and support the incorporation of AI, machine learning, and automation in HCS Buy-Now this Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/3487 © Coherent market Insights. All Rights Reserved

5. ABOUT COHERENT MARKET INSIGHTS ABOUT US Coherent Market Insights is a global market intelligence and consulting organization focused on assisting its plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, with an office at the global financial capital in the U.S. Our client base includes players from across all business verticals in over 150 countries worldwide. We are uniquely positioned to help businesses around the globe deliver practical and lasting results through various recommendations about operational improvements, technologies, emerging market trends and new working methods. We offer both customized and syndicated market research reports that help our clients create visionary growth plans to provide traction to their business. We meticulously study emerging trends across various industries at both the global and regional levels to identify new opportunities for our clientele. SERVICES CUSTOMIZED RESEARCH INDUSTRY ANALYSIS SYNDICATED RESEARCH COUNTRY SPECIFIC STUDIES MARKET INTELLIGENCE SERVICES CONSULT STUDIES © Coherent market Insights. All Rights Reserved

6. ABOUT CMI SECTOR COVERAGE BIOTECHNOLOGY CLINICAL DIAGNOSTIC HEALTHCARE IT MEDICAL DEVICES MEDICAL IMAGING PHARMACEUTICAL OUR CLIENTS  Global Leading Equipment and System Manufacturers  Marketing Consultancies and the Advertising Industry  Component Providers and System Integrators  Private and Government organization  Distributors, Retailors and Value Added Resellers  Outsourcing Companies  Healthcare IT Solutions Developers  Universities and Business Schools. © Coherent market Insights. All Rights Reserved

7. KEY STATS RESEARCH SOLUTIONS 100+ GLOBAL REPORTS FEASIBILITY STUDIES Insights Published Per Year CUSTOMIZED SOLUTIONS 150+ COUNTRY ANALYSIS Consulting Projects Till Date CONSULT PROJECTS SURVEY RESEARCH 125+ EXCEL FORECAST DATABASE Clients Worldwide Per Year COMPETITIVE ASSESSMENT TECHNOLOGY SNIPPETS 110+ Analysts and Contract Consultants Coherent Market Insights excels at offering unmatched actionable market intelligence across various industry verticals, including chemicals, healthcare, and food & beverages, to name a few. We implement holistic market research methodology in order to result in the best possible market research reports across various industries worldwide. Based on our unmatched expertise across various industries—no matter how large or small, how complex or unique—we help our clients achieve better outcomes with uniquely designed and highly customized solutions. Our coverage includes insights that help our clients ensure sustained growth in developed markets and also key inputs to help them tap into emerging markets and exploit the plethora of opportunities posed therein. © Coherent market Insights. All Rights Reserved

8. THANK YOU To know more about us, visit our website: www.coherentmarketinsights.com For sales queries or new topics email us on: sales@coherentmarketinsights.com For other queries contact: Mr. Shah (Manager - Business Development) Coherent Market Insights sales@coherentmarketinsights.com +1-206-701-6702 © Coherent market Insights. All Rights Reserved